99% Savings - Buy Just @1 Rs X
Melanex, a prescription drug, is manufactured in various forms such as Tablet. Cutaneous T-Cell Lymphomas are some of its major therapeutic uses. Melanex also has some secondary and off-label uses. These are listed below.
The optimal dosage of Melanex is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Melanex also has some side effects, the most common being Skin redness, Blisters on skin. Some other side effects of Melanex have been listed ahead. Normally, these side effects of Melanex are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Melanex's effect during pregnancy is Unknown and Unknown while nursing. Warnings related to Melanex's effects on the liver, heart and kidney, if any, have been listed below.
Melanex can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Melanex in conditions like Porphyria, Xeroderma Pigmentosum, Skin Cancer. Other conditions have been mentioned below in the Melanex contraindications section.
Additionally, Melanex may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Melanex is safe while driving, and is addiction.
Melanex is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Melanex safe for pregnant women?
Side effects of Melanex during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Melanex safe during breastfeeding?
Information about safety of Melanex for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Melanex on the Kidneys?
Melanex may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Melanex on the Liver?
There may be an adverse effect on the liver after taking Melanex. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Melanex on the Heart?
Side effects of Melanex rarely affect the heart.
Melanex should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Melanex unless your doctor advises you to do so -
Is this Melanex habit forming or addictive?
No, there is no any evidence that Melanex is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Melanex since it does not cause drowsiness.
Is it safe?
Yes, Melanex is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Melanex cannot treat any kind of mental disorder.
Interaction between Food and Melanex
Melanex may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Melanex
No research has been done on this till date. Therefore, it is not known what the effect of taking Melanex with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Uvadex® (methoxsalen)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 890-891